As many of our PVC patients showed a tumoral and immune cell PD-L1 expression, an immune modulatory microenvironment similar to cervical cancer may be present in PVC, thereby supporting the current concept of therapy adaption to that of cervical cancer and vulvar cancer, especially with regard to immunotherapy. The gene discussed is CD274; the disease is vulva cancer.